Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText.
Kick-your-searchterm to multiple Engines kick-your-query now !>
A dictionary by aggregated review articles of nephrology, medicine and the life sciences
Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

suck abstract from ncbi


10.1016/j.jcrc.2020.05.017

http://scihub22266oqcxt.onion/10.1016/j.jcrc.2020.05.017
suck pdf from google scholar
32512349!7256550!32512349
unlimited free pdf from europmc32512349    free
PDF from PMC    free
html from PMC    free
PDF vom PMID32512349  :  Publisher
PDF vom PMID32512349  :  Publisher
PDF vom PMID32512349
PDF vom PMID32512349

suck abstract from ncbi

pmid32512349
Nephropedia Template TP

gab.com Text

Twit Text FOAVip

Twit Text #

English Wikipedia


  • Clinically significant anticardiolipin antibodies associated with COVID-19 #MMPMID32512349
  • Hossri S; Shadi M; Hamarsha Z; Schneider R; El-Sayegh D
  • J Crit Care 2020[Oct]; 59 (ä): 32-34 PMID32512349show ga
  • The novel coronavirus strain known as SARS-CoV-2 has rapidly spread around the world creating distinct challenges to the healthcare workforce. Coagulopathy contributing to significant morbidity in critically ill patients with SARS-CoV-2 has now been well documented. We discuss two cases selected from patients requiring critical care in April 2020 in New York City with a unique clinical course. Both cases reveal significant thrombotic events noted on imaging during their hospital course. Obtaining serial inflammatory markers in conjunction with anti-phospholipid antibody testing revealed clinically significant Antiphospholipid syndrome (APS). This case series reviews the details preceding APS observed in SARS-CoV-2 and aims to report findings that could potentially further our understanding of the disease.
  • |Adult[MESH]
  • |Antibodies, Anticardiolipin/*immunology[MESH]
  • |Antibodies, Monoclonal, Humanized/therapeutic use[MESH]
  • |Anticoagulants/therapeutic use[MESH]
  • |Antiphospholipid Syndrome/*blood/complications/immunology[MESH]
  • |Antiviral Agents/therapeutic use[MESH]
  • |Arterial Occlusive Diseases/etiology[MESH]
  • |Betacoronavirus[MESH]
  • |COVID-19[MESH]
  • |Cerebral Infarction/etiology[MESH]
  • |Computed Tomography Angiography[MESH]
  • |Coronavirus Infections/*blood/complications/drug therapy/immunology[MESH]
  • |Critical Illness[MESH]
  • |Female[MESH]
  • |Heparin/therapeutic use[MESH]
  • |Humans[MESH]
  • |Hydroxychloroquine/therapeutic use[MESH]
  • |Interleukin 1 Receptor Antagonist Protein/therapeutic use[MESH]
  • |Male[MESH]
  • |Middle Aged[MESH]
  • |New York City[MESH]
  • |Pandemics[MESH]
  • |Pneumonia, Viral/*blood/complications/drug therapy/immunology[MESH]
  • |SARS-CoV-2[MESH]
  • |Splenic Infarction/etiology[MESH]
  • |Thrombosis/*blood/drug therapy/etiology[MESH]
  • |Tibial Arteries[MESH]


  • DeepDyve
  • Pubget Overpricing
  • suck abstract from ncbi

    32 ä.59 2020